Cellebrite Furthers Global Commitment and Partnerships with Global Law Enforcement Community at International Association of Chiefs of Police Conference
TYSONS CORNER, Va. and PETAH TIKVA, Israel and SAN DIEGO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence (“DI”) solutions for the public and private sectors, wrapped up a four-day presence at the 2023 International Association of Chiefs of Police (IACP) Annual Conference and Exposition. More than 16,000 police chiefs and other senior law enforcement professionals attended the single largest and most impactful law enforcement event of the year.
“IACP is a landmark event in the law enforcement community, and we are pleased to take this opportunity to reinforce our strong ties and relationships with law enforcement professionals,” said Yossi Carmil, Cellebrite CEO. “These officials understand perhaps better than most, how our shared mission for justice never sleeps, and I am incredibly grateful for their passion, drive and dedication. I am equally grateful for my team for their unrelenting efforts in support of our business and customers around the world.”
Highlights of Cellebrite’s event presence include:
- Center-floor exhibition booth space with demonstrations and presentations of the full suite of Cellebrite end-to-end solutions for the public sector including Pathfinder and Guardian;
- Cellebrite’s CEO and President of North America convened with DEA senior leadership, 132 senior law enforcement and chief leaders to discuss streamlining and modernizing the handling of digital data from time of extraction to prosecution;
- Multiple meetings with key officials representing many of the largest cities across America with 60 product demonstrations and more than 500 times as many booth visits when compared to 2022;
- An interactive “Solve Suite” where law enforcement gained hands-on experience using Cellebrite’s powerful digital intelligence solutions, including demoing its newest innovation, Smart Search, which led a police chief to expedite a request for Cellebrite solutions that was sitting on his desk;
- Panel moderation by Jared Barnhart, Digital Intelligence Specialist at Cellebrite, with key partners in the fight against human trafficking, including the National Center for Missing and Exploited Children (NCMEC), the Exodus Road and Raven – this powerful panel was one of the top-attended programs at the event;
- Presentation of “Unraveling Crime Mysteries” with Jared Barnhart, Digital Intelligence Specialist at Cellebrite, who shared his law enforcement expertise while discussing real-world examples of how digital intelligence solutions can enhance investigations to solve cases faster, smarter and more defensibly to accelerate justice;
- Connect Lounge Sponsorship, a popular meeting spot for law enforcement professionals to network with one another
The panel discussion on child trafficking was a remarkable convergence of global leaders committed to safeguarding children worldwide. They united to synergize their collective expertise for an accelerated mission. It called upon all law enforcement agencies and technology vendors to integrate cutting-edge solutions and increase the number of rescued children. The “Unraveling Crime Mysteries” presentation illuminated cases solved through technology, emphasizing the need for agencies to adopt smarter, tech-driven approaches. In its entirety, these platforms at IACP emphasized Cellebrite's unwavering commitment to collaborate with philanthropic and agency partners, aiming to make the modernization of investigations a reality, simplifying and expediting critical cases.
“I am so proud to be part of the Cellebrite team and to witness the partnership we have with the brave individuals in law enforcement both stateside and around the world,” Marque Teegardin, President, Cellebrite Americas. “Our agile, global team is steadfast in our support for one another, and we remain committed to ensuring our customers and partners are always equipped, ready and Cellebrite-powered.”
Sr. Director of Corporate Communications + Content Operations
Investor Relations Contact:
Vice President, Investor Relations
Cellebrite’s (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
XPENG G9 Achieves a Five-Star 2023 Safety Rating from Euro NCAP6.12.2023 11:00:00 CET | Press release
The new XPENG G9, now on sale in Europe, received a five-star 2023 safety rating from Euro NCAPThis is XPENG's second five-star safety rating for an international model following the new P7 in October; and its first SUV obtained both Euro NCAP and C-NCAP five-star ratings AMSTERDAM, Dec. 06, 2023 (GLOBE NEWSWIRE) -- XPENG Motors (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announces that the international model of their flagship electric SUV, XPENG G9, has received a five-star 2023 safety rating from Euro NCAP. Euro NCAP's five-star safety rating system aims to help consumers, their families and businesses compare vehicles more easily and identify the safest choice for their needs. The tests, which replicate real-life road danger scenarios, represent the European gold standard for comprehensive automotive safety testing. The rating recognises the XPENG G9's advanced body structure and comprehensive passive s
AS Tallink Grupp: Managers’ Transactions6.12.2023 11:00:00 CET | Press release
Person subject to the notification requirement Name: AS Infortar Position: Closely associated person (X) Legal person Person Discharging Managerial Responsibilities in Issuer Name: Hanschmidt, Ain Position: Member of the Supervisory Board Name: Pant, Eve Position: Member of the Supervisory Board Issuer: AS Tallink Grupp LEI: 529900QRMWAKKR3L9W75 Notification type: Initial Notification _____________________________________ Transaction date: 04.12.2023 Venue: Nasdaq OMX Tallinn Instrument type: Share ISIN: EE3100004466 Nature of the transaction: Acquisition Transaction details: (1): Volume: 105,178; Unit price: 0.68 EUR Aggregated transactions: (2): Volume: 105,178; Volume weighted average price: 0.68 EUR Anneli Simm Investor Relations Manager AS Tallink Grupp Sadama 5 10111 Tallinn E-mail Anneli.firstname.lastname@example.org
CDR-Life Announces First Patient Dosed in Phase 1 Study with Boehringer Ingelheim Evaluating Potential Treatment for Geographic Atrophy6.12.2023 11:00:00 CET | Press release
ZÜRICH, Switzerland, Dec. 06, 2023 (GLOBE NEWSWIRE) -- CDR-Life Inc. today announced that the first patient has been dosed in the Phase 1 trial of BI 771716 for the treatment of geographic atrophy (GA). Licensed to Boehringer Ingelheim, BI 771716 is a highly specific antibody fragment of reduced size, enabling an optimized penetration through all retinal layers to the most critical target site driving GA disease pathology. The Phase 1 study (NCT06006585) is evaluating the safety, tolerability and pharmacokinetics of intravitreal single rising doses and multiple doses of BI 771716 as a potential treatment for GA. GA is a chronic and progressive, irreversible retinal disease that occurs in people with late-stage dry age-related macular degeneration (AMD) impacting the ability to see. More than 5 million people worldwide suffer from GA, of which more than 40% are legally blind. GA worsens with age, affecting 1 in 29 people above the age of 75 and 1 in 4 people above 90. Consequently, risi
ForFarmers N.V.: Approval competition authority for the acquisition of Piast Pasze Sp. z.o.o.6.12.2023 10:30:00 CET | Press release
Lochem, 6 December 2023 Approval competition authority for the acquisition of Piast Pasze Sp. z.o.o. Today, ForFarmers received approval from the Polish competition authority to acquire Piast Pasze Sp. z.o.o. ("Piast"). With this transaction, announced on 25 July 2023, ForFarmers/Tasomix's volume in Poland will expand by 410,000 tonnes, strengthening its position in the broiler sector in particular. Parties will work towards a closing of the acquisition. This transaction is in line with ForFarmers/Tasomix's strategic objectives to expand in the attractive Polish agricultural market. This press release contains information that qualifies as inside information within the meaning of Article 7 paragraph 1 of the EU Market Abuse Regulation. Note to the editor / For further information: Floor van Maaren, T: 06-29597746 Paweł Świerkula, Managing Director ForFarmers/Tasomix M + 48 510 22 00 22 • E: email@example.com About ForFarmers ForFarmers N.V. is an international organisation tha
Resultat af auktion over 1,75 pct. Danske Stat 2025 og 2,25 pct. Danske Stat 20336.12.2023 10:26:31 CET | pressemeddelelse
Bud, salg, skæringspris, pro rata og effektiv rente fremgår af nedenstående oversigt: ISINBud mio. kr. (nominelt)SalgSkæringskursPro-rataEffektiv rente, pct. p.a.99 23138 1,75% 15/11/20251.8601.10098,34100 %2,6499 24532 2,25% 15/11/2033300 300 97,80100 %2,50I alt2.1601.400 Salget bliver afviklet den 8. december 2023.